Search
Search Results
-
Lipoprotein(a): what clinicians need to know
322PDF: 676HTML: 23 -
Modulation of cardiac metabolism in heart failure
2350PDF: 1148HTML: 26 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
1087PDF: 28Supplementary: 316Appendix: 264 -
Epidemiology of peripartum cardiomyopathy in Africa
2269PDF: 502HTML: 96 -
-
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
183PDF: 232Supplementary: 147HTML: 21 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
764PDF: 216Supplementary: 142Appendix: 111HTML: 33 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
1128PDF: 575Appendix: 236HTML: 19 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
778PDF: 194Supplementary: 151Appendix: 105HTML: 37 -
Evolving targets for heart failure: the journey so far
2036pdf: 327HTML: 4 -
The impact of frailty on in-hospital outcomes in patients with HFrEF
131PDF: 51Supplementary: 10HTML: 1 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1116pdf: 244Supplementary Material: 40HTML: 121 -
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3364PDF: 532Appendix: 390HTML: 26

